Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival

Human Pathology

Volumn 33, Issue 11, 2002, Pages 1086-1091

  Wolberg, William H ^a,b   Nick Street, W ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Breast cancer; Computer analysis; Image analysis; Prognosis; Telemedicine

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; CELL NUCLEUS; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; SURVIVAL RATE; TISSUE SLICE; TUMOR VOLUME;

EID: 0036858715     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.129198     Document Type: Article

References (33)

1. Fitzgibbons PL, Page DL, Weaver D, et al: Prognostic factors in breast cancer - College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966-978, 2000
2. Street WN, Wolberg WH, Mangasarian OL: Nuclear feature extraction for breast tumor diagnosis. Proc IS&T/SPIE Int Symp Elec Imag 1905:861-870, 1993
3. Wolbmg WH, Street WN, Mangasarian OL: Importance of nuclear morphology in breast cancer prognosis. Clin Cancer Res 5:3542-3548, 1999
4. Wolberg WH, Street WN, Mangasarian OL: Computer-derived nuclear features compared with axillary lymph node status for breast carcinoma prognosis. Cancer (Cancer Cytopathol) 81:172-179, 1997
5. Adair F, Berg J, Joubert L, et al: Long-term follow-up of breast cancer patients: The 30-year report. Cancer 33:1145-1150, 1974
6. Langlands AO, Pocock SJ, Ken GR, et al: Long-term survival of patients with breast cancer: A study of the curability of the disease. Br Med J 2:1247-1251, 1979
7. Kerr GR, Kunkler IH, Langlands AO, et al: (In)curability of breast cancer - A 30-year report of a series of 3933 cases. Breast 7:90-94, 1998
8. Street WN: Xcyt: A system for remote cytological diagnosis and prognosis of breast cancer, in Jain LC (ed): Soft Computing Techniques in Breast Cancer Prognosis and Diagnosis. Singapore, World Scientific Publishing, 2000, pp 297-322
9. Mandelbrot BB: The Fractal Geometry of Nature. New York, NY, Freeman, 1977
10. SPSS for Windows: Base System, Release 7.5. Chicago, IL, SPSS Inc., 1997
11. SPSS Advanced Statistics 7.5. Chicago, IL, SPSS Inc., 1997
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Baak JPA, VanDiest PJ, Stroet-Van Galen C, et al: Data processing and analysis in the multicenter morphometric mammary carcinoma project. Pathol Res Pract 185:657-663, 1989
14. Bloom H, Richardson W: Histological grading and prognosis in breast cancer. Br J Cancer 19:359-377, 1957
15. Boiesen P, Bendahl PO, Anagnostaki L, et al: Histologic grading in breast cancer - Reproducibility between seven pathologic departments. Acta Oncol 39:41-45, 2000
16. American Joint Committee on Cancer: Breast cancer staging, in American Joint Committee on Cancer: Manual for Staging of Cancer. Philadelphia, PA, Lippincott Williams and Wilkins, 1982
17. Warmuth MA, Bowen G, Prosnitz LR, et al: Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer 83:1362-1368, 1998
18. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-399, 1995
19. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 339:941-946, 1998
20. Baak JPA, Kurver PHJ, Snoo-Niewlaat AJE, et al: Prognostic indicators in breast cancer: Morphometric methods. Histopathology 6:327-339, 1982
21. Baak JPA, VanDop H, Kurver PHJ, et al: The value of morphometry to classic prognosticators in breast cancer. Cancer 56:374-382, 1985
22. Stenkvist B, Westman-Naeser S, Vegelius J, et al: Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32:979-985, 1979
23. Wittekind C, Schulte E: Computerized morphometric image analysis of cytologic nuclear parameters in breast cancer. Anal Quant Cytol Histol 9:480-484, 1987
24. Fregene TA, Khanuja PS, George J, et al: Nuclear morphometry predicts for disease recurrence in early stage breast cancer [meeting abstract]. Proc Ann Meet Am Assoc Cancer Res 35:A1354, 1994
25. Eskelinen MJ, Pajarinen P, Collan Y, et al: Relationship between DNA ploidy and survival in patients with primary breast cancer. Br J Surg 76:830-834, 1989
26. Dressler LG, Seamer LC, Owens MA, et al: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61:420-427, 1988
27. Fallenius AG, Auer GU, Carstensen JM: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 62:331-341, 1988
28. Kallioniemi OP, Blanco G, Alavaikko M, et al: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62:2183-2190, 1988
29. Sundquist M, Thorstenson S, Brudin L, et al: A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer. Breast Cancer Res Treat 63:11-15, 2000
30. Donegan WL: Tumor-related prognostic factors for breast cancer. CA Cancer J Clin 47:28-51, 1997
31. Tormey DC, Taylor SGI, Olson JE, et al: Adjuvant systemic therapy in premenopausal (CMF, CMFP, CMFPT) and postmenopausal (observation, CMFP, CMFPT) women with node-positive breast cancer, in Salmon SS (ed): Adjuvant Therapy of Cancer, Vol IV. Philadelphia, PA, Lippincott Williams and Wilkins, 1984, pp 359-368
32. Cummings FJ, Gray R, Davis TE, et al: Adjuvant tamoxifen treatment of elderly women with stage II breast cancer: A double-blind comparison with placebo. Ann Int Med 103:324-329, 1985
33. Taylor SG IV, Kuniman MW, Sleeper LA, et al: Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. J Clin Oncol 7:879-889, 1989